Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
269 Cards in this Set
- Front
- Back
CO: mechanism of toxicity?
|
[asphyxiant]
competitively binds Hb 200x better than O2 |
|
CO toxicity: Tx?
|
[asphyxiant]
100% O2 |
|
CN: mech of toxicity?
|
[asphyxiant]
binds Fe3+ of complex IV of electron transport chain (cyt a3) --> chain can't deliver e- to O2 = NO ATP SYNTH! |
|
CN toxicity: Tx?
|
[asphyxiant]
Nitrite (NO2-) inhalation/injection rhodanase (body enzyme) converts CN- into SCN- (thiocynate) and SO3 |
|
What is a chemical Asphyxiant?
|
interfere with cell's ability to get/use O2
|
|
What's the risk for paint strippers?
|
methylene dichloride can be converted to CO (asphyxiant) in liver
|
|
List the URT pollutants?
|
SO2 (Sulfur dioxide)
|
|
List the deep lung pollutants?
|
O3 (Ozone), NO2 (Nitrogen dioxide)
|
|
CO: Sx of toxicity?
|
[asphyxiant]
tissue hypoxia: HA, confusion, syncope, tachycardia, brain damage |
|
Which pollutants are water soluble?
|
SO2
(not O3 or NO2) |
|
MC Sx SO2 poisoning?
|
[pollutant]
bronchoconstriction (esp asthma pt) also conjunctival irritation |
|
Which Pollutants have immediate irritation vs. delayed irritation?
|
immediate: SO2
delayed: O3, NO2 |
|
Sources of SO2?
|
[pollutant]
burning coal, acid rain |
|
What pollutant are farmers at risk for?
|
NO2, found in silage (cowfeed)
|
|
List the Aromatic hydrocarbons?
|
[solvents]
Benzene, Toluene, Xylene |
|
Aromatic hydrocarbons: mech of toxicity?
|
[solvents] (Benzene, Toluene, Xylene)
Organic solvents are CNS depressants liver: Benzene metabolized (epoxidation) by P450 --> becomes mutagenic (genotoxin) BM: Benzene is myelotoxic (thrombocytopenia, leukopenia, aplastic anemia) |
|
List the Alcohol solvents?
|
Methanol, Ethylene glycol
|
|
Methanol: mech of toxicity?
|
[alcohol solvents]
metabo'd to Formaldehyde: binds proteins, water soluble, URT irritant Formaldehyde metabo'd into Formic Acid: retinal toxicity, systemic acidosis |
|
Methanol toxicity: Tx?
|
[alcohol solvents]
Ethanol: competes w/ methanol for metabolic enzymes (ADH) - so methanol not broken down to toxic Formaldehyde and Formic acid |
|
Ethylene glycol (antifreeze): mech of toxicity?
|
[alcohol solvents]
metabo'd to Oxalic acid: acidosis, kidney damage (oxalate crystals) |
|
List the toxic Solvents?
|
Aromatic hydrocarbons: Benzene/Toluene/Xylenes
Alcohols: Methanol, Ethylene glycol Aliphatic hydrocarbons (gasoline) Halogenated hydrocabons (methylene chloride, chloroform, CCl4, halothane) |
|
Halogenated hydrocarbons: mech of toxicity?
|
[solvents] (methylene chloride, chloroform, CCl4, halothane)
P450 dependent: methylene chloride --> CO (asphyxiant) chloroform --> phosgene (pneumonitis) CCl4 --> CCl3' radical halothane --> radical (halothane hepatitis) Also CNS depression, nephrotoxic, hepatotoxic, genotoxic |
|
List the Organophosphates?
|
[insecticides]
Parathion, Malathion |
|
Organophosphates: MOA?
|
[insecticides] (Parathion, Malathion)
Inhibits AChE via phosphorylation --> ACh accumulation paralyzes cholinergic transmission in CNS/PNS = kills insect! |
|
Organophosphate: Tx?
|
[insecticides] (Parathion, Malathion)
Pralidoxime: dephosphorylate AChE --> reactivates Atropine: reverse cholinergic poisoning Cholestyramine: ^fecal excretion |
|
Organophosphates: Sx of toxicity?
|
[insecticides]
"cholinergic poisoning": pinpoint pupils, sweating, bronchoconstriction, m fasciculations, paralysis MCC death: resp failure OPIDN (organophosphate-induced delayed neuropathy): ataxia, paralysis, axon/myelin degeneration, UMN lesion in legs |
|
List the Carbamates?
|
[insecticides]
Carbaryl, Baygon |
|
Carbamates: MOA?
|
[insecticides] (Carbaryl, Baygon)
inhibit AChE by carbamoylation |
|
Carbamates: Sx of toxicity?
|
[insecticides] (Carbaryl, Baygon)
"cholinergic poisoning" (like Organophosphates): pinpoint pupils, sweating, bronchoconstriction, m fasciculations, paralysis |
|
Carbamates: Tx?
|
[insecticides] (Carbaryl, Baygon)
Oximes (decarbamylater) (Pralidoxime not effective, used for Organophosphates) |
|
Nicotine: MOA?
|
[insecticides]
ANS ganglion, NMJ blocker |
|
Nicotine: toxicity?
|
[insecticides]
@ high doses: loss of m fxn, resp paralysis |
|
List the Household insecticides?
|
Pyrethrum, Rotenone
|
|
Rotenone: MOA?
|
[household insecticides]
bind complex I of ETC --> no ATP synth! |
|
Rotenone: toxicity?
|
[household insecticides]
GI irritation |
|
Pyrethrum: toxicity?
|
[household insecticides]
affects CNS: excitation, convulsions, tetanic paralysis |
|
Pyrethrum: Tx?
|
[household insecticides]
Ivermectin (Cl- agonist) |
|
List the Herbicides?
|
Paraquat, Chlorophenoxy compounds (agent orange)
|
|
Chlorophenoxy cmpds: MOA?
|
[herbicides]
probably uncoupling of oxidative phosphorylation |
|
Chlorophenoxy cmds: Sx of toxicity?
|
[herbicides]
infertility, carcinogenic (NHL), teratogenic, coma/hypotonia |
|
Chlorophenoxy cmpds: toxic contaminant?
|
[herbicides]
TCDD (2,3,7,8-TetraChloroDibenzo-p-Dioxin) is toxic |
|
Paraquat: mech of toxicity?
|
[herbicides]
metabo'd to free radical (O2-) --> causes lipid peroxidation |
|
Paraquat: Sx of toxicity?
|
[herbicides]
lung (edema, fibrosis) |
|
Paraquat: Tx?
|
[herbicides]
gastric lavage (rinsing), mineral adsorbents, hemoperfusion CI: hyperbaric O2 (exacerbates oxidative damage) |
|
List the Insecticides?
|
Nicotine
Organophosphates (Parathion, Malathion) Chlorinated hydrocarbons (DDT, lindane) Carbamates (Carbaryl, Baygon) Household insecticides (Pyrethrum, Rotenone) |
|
Warfarin rodenticide: MOA?
|
inhibit vit K-dependent factors (coags: II, VII, IX, X); massive systemic hemorrhage
|
|
List the Chlorinated hydrocarbons?
|
[insecticides]
DDT, Lindane |
|
Chlorinated hydrocarbons: MOA? Sx of toxicity?
|
[insecticides] (DDT, Lindane)
inhibition of repolarization = interfere with inactivation of Na channels --> rapid firing of neurons convulsions, tremors |
|
List the Heavy Metals?
|
Mercury, Lead, Arsenic, Cadmium, Iron
|
|
Lead: Tx?
|
[heavy metal]
severe: EDTA (iv), Dimercaprol (im) mild: Dimercaptosuccinate (Succimer) (oral), Penicillamine (oral) |
|
Lead: mech of toxicity?
|
[heavy metal]
inhibits heme synth: binds σ-ALA synthase/dehydratase/ferrochelatase --> accum of d-aminolevulonic acid and protoporphyrin IX (plasma/urine) |
|
Lead: Sx of toxicity
|
[heavy metal]
Pica, anemia, encephalopathy, periph neuropathy (wristdrop) (from lecture) Acute/sub-acute: abd pain, HA, encephalopthy, anemia (no lead lines in gums) |
|
Lead: absorption route?
|
[heavy metal]
inhalation, oral (kids) |
|
Cadmium: absorption route?
|
[heavy metal]
inhalation, oral |
|
Cadmium: mech of toxicity?
|
[heavy metal]
lung: inhibits a1AT --> emphysema oral: proximal tubular injury (kidney) --> proteinuria, B2-macroglobulin |
|
Cadmium: Tx?
|
[heavy metal]
EDTA (iv) |
|
Why is dimercaprol CI in cadmium toxicity?
|
[chelator]
oral cadmium toxicity causes proximal tubular injury (kidney) Dimercaprol-Cadmium complex is extremely nephrotoxic! don't use any thiol-containing drugs (^nephrotoxic) |
|
Mercury: route of absorption?
|
[heavy metal]
oral (Hg salts can be converted to organic salt by gut flora = 90% abs), inhalation |
|
Mercury: mech of toxicity?
|
[heavy metal]
Hg salts cause precipitation of proteins and destroys mucosal membranes --> hemorrhagic gastroenteritis proximal tubular necrosis inhibits sulfhydryl-containing enzymes |
|
What is Minamata dz?
|
[heavy metal] (Mercury)
1950s birth defect epidemic in Japanese village due to methylmercury-contaminated seafood from factory) |
|
Mercury: Tx?
|
[heavy metal]
N-acetyl Penacillamine (oral) - most effective also Dimercaprol (im), Dimercaptosuccinate (Succimer) (oral) |
|
Arsenic: route of absorption?
|
[heavy metal]
oral (very good), inhalation |
|
Arsenic: mech of toxicity?
|
[heavy metal]
1. protein damage of caps increases vasc permeability --> vasodilation, vascular collapse, shock 2. inhibits anaerobic and oxidative phosphorylation 3. inhibits sulfhydryl-containing enzymes 4. Ar gas: intravascular hemolysis, oliguric renal failure |
|
Arsenic: Tx of toxicity?
|
[heavy metal]
chelation (Penicillamine) not very beneficial -- supportive therapy -- for acute toxicity: fluid/electrolyte replacement, BP support (dopamine) for chronic toxicity: transfusion |
|
Iron: route of absorption?
|
[heavy metal]
skin, oral (duod/jej), inhalation |
|
Iron: storage?
|
[heavy metal]
in hepatocytes and reticuloendothelial cells (also muscle) |
|
Iron: mech of toxicity?
|
[heavy metal]
oxidative damage: lipid peroxidation, damages liver (major storage site), heart, pancreas, ant. pituitary |
|
Iron: Sx of toxicity?
|
[heavy metal]
GI bleed, gray cyanosis, jaundice |
|
Iron: Tx?
|
[heavy metal]
Chelator: Deferoxamine (im/iv) |
|
Why is EDTA given IV?
|
[chelator for Lead, Cadmium]
cannot cross cell membranes |
|
Why is EDTA given as a calcium disodium salt?
|
[chelator for Lead, Cadmium]
to balance the calcium level |
|
Copper (Wilson's dz): Tx?
|
Pencillamine, N-acetyl-penicillamine (oral)
if allergic, use Trientine |
|
Half-lives:
As? Hg? Cd? Pb? |
[heavy metals]
As: 10hrs Hg: 70days Cd: 20yrs Pb: 2mo in blood, 40yrs in bone |
|
EDTA: site of action?
|
[chelators]
only chelates circulating metals bc can't cross membranes (highly polar) |
|
EDTA: uses?
|
[chelators]
severe Pb poisoning, also cadmium |
|
EDTA: toxicity?
|
[chelators] (for Pb, Cd)
renal tubular necrosis (metal-EDTA complex) thrombophlebitis w/ rapid infusion |
|
Dimercaprol: uses?
|
[chelators]
As, Hg, Pb (severe) poisoning |
|
Dimercaprol: route of administration?
|
[chelators]
IM in peanut oil |
|
Dimercaprol: mech of toxicity?
|
[chelators]
highly lipophilic = crosses membranes easily (high rate toxicity, 50%) convulsions, HTN (from tachycardia and peripheral vasoconstriction), renal toxicity (reduce by alkalinizing urine) |
|
Deferoxamine: uses?
|
[chelators]
iron poisoning |
|
Deferoxamine: toxicity?
|
[chelators]
skin rash, histamine rls & shock, cataracts |
|
Penicillamine: uses?
|
[chelators]
Pb, As, Hg, Cu (Wilson's) poisoning |
|
What do you use when you're allergic to Penicillamine?
|
[chelators for Cu]
Trientine (triethylenetetramine) - teratogenic |
|
Penicillamine: toxicity?
|
[chelator]
Vitamin B6 (pyridoxine) def, leucopenia, anaphylaxis |
|
Dimercaptosuccinate (Succimer): uses?
|
[chelator]
As, Hg, Pb (mild) poisoning |
|
Dimercaptosuccinate (Succimer): toxicity?
|
[chelator]
GI problems |
|
Dimercaptosuccinate (Succimer): route of admin?
|
[chelator]
oral |
|
What can aflatoxin lead to?
|
[carcinogen]
liver CA |
|
What can carcinogenic viruses lead to?
|
[carcinogen]
lymphosarcoma |
|
What can carcinogenic dyes lead to?
|
[carcinogen]
bladder CA |
|
What is the 2 stage theory of carcinogenesis?
|
1. Initiation: alter DNA like p53 (single exposure sufficient) - eg. polycyclic hydrocarbones, benzopyrines, halogenated hydrocarbons, aflatoxin B1
2. Promotion: stim cell prolif (multiple exposures necessary) - eg. sex hormones, EGF, tetradecanoyl phorbol acetate (TPA), PKC |
|
List the polycyclic aromatic hydrocarbons?
|
[carcinogens]
Benzo(a)pyrene |
|
How are polycyclic hydrocarbons activated to interact with DNA?
|
[carcinogens] (Benzo(a)pyrene)
1. P450 mediated oxidation 2. epoxide formation 3. N-oxidation 4. converts non-polar hydrocarbons to polar compounds by adding oxygen so that it can interact with DNA (same with aflatoxin B1) |
|
List the pathways that eliminate mutagenic cmpds? (4)
|
1. glutathione conjugation: X + GSH --> X-GSH (mercapturic acid, not reactive)
2. epoxide hydrolase: converts epoxides to trans-dihydrodiols (excreted) 3. glucoronidation: makes things more water-soluble (urinate) 4. sulfation: uses PAPs to transfer sulfonate to drugs |
|
What type of mutation can mutagenic alkylations lead to on DNA?
|
point mutations
|
|
What type of mutation can mutagenic adducts lead to on DNA?
|
frame shift mutations
eg. Benzo(a)pyrene, Aflatoxin B1 |
|
Xeroderma pigmentosum: defect?
|
defective nucleotide excision repair --> DNA damage by UV (AR)
|
|
Cigarette smoke contains which carcinogens?
|
[carcinogens]
Benzo(a)pyrene (Polycyclic aromatic hydrocabon) Dimethylnitrosamine (Nitrosamines) - food perservatives 2-acetylaminofluorine (Aromatic amines) - dyes |
|
Benzo(a)pyrene: mech of toxicity?
|
[carcinogens] (Polycyclic aromatic hydrocarbons)
activated by P450 epoxidation, forms adduct with guanosine --> frame shift mut |
|
Dimethylnitrosamine: mech of toxicity?
|
[carcinogens] (Nitrosamines)
activated by acidic stomach |
|
2-acetylaminofluorine: can cause?
|
[carcinogens] (Aromatic amines)
bladder CA in smokers |
|
Aflaxtoxin B1: mech of toxicity? can cause?
|
[carcinogens]
activated by liver epoxidation (P450) from Aspergillus in peanuts --> forms adduct with guanosine --> frame-shift mut HCC |
|
Vinyl chloride: can be found where? and what can it cause?
|
[carcinogens] (Halogenated cmpds)
plastics industry (PVC pipes) angiosarcoma of liver |
|
Vinyl chloride: mech of toxicity?
|
[carcinogens] (Halogenated cmpds)
activated by GSH conjugation (not eliminated) and P450 |
|
Which carcinogens form adduct with guanosine and cause frame-shift muts?
|
[carinogens]
Benzo(a)pyrene (Polycyclic aromatic hydrocarbons) Aflatoxin B1 (mycotoxin) (these also require activation via P450-mediated epoxidation to bind DNA) |
|
Compare short-, intermediate-, long-acting glugocorticoids?
|
short-acting: anti-inflamm effect = Na-retaining effect, 8-12hr (Hydrocortisone)
intermediate-acting: mostly anti-inflamm effect, 12-24hr (Prednisone/Prednisolone/Trimcinolone) long-acting: only anti-inflamm effect, 24-36hr (Dexamethasone/Betamethasone) |
|
Important SE/CI of glucocorticoids?
|
HTN!
don't give hydrocrotisone to someone with HTN |
|
Tx for Addison's dz?
|
[glucocorticoids]
Hydrocortisone Addison's dz = primary adrenocortical insufficiency |
|
Dx of Cushing's syndrome?
|
[glucocorticoids]
Dexamethasone suppression test |
|
Tx for acute asthma attack?
|
[glucocorticoids]
oral Prednisolone |
|
Tx for chronic asthma attack?
|
[glucocorticoids]
inhalation therapy with glucocorticoids |
|
List the glucocorticoids? (6)
|
Hydrocortisone
Prednisone Prednisolone Triamcinolone Dexamethasone Betamethasone |
|
Glucocorticoids: SE?
|
HTN
topical: impaired wound healing, cataracts, skin atrophy |
|
Glucocorticoids: MOA?
|
anti-inflamm and immunosuppressive:
decrease peripheral WBCs inhibits AA synth blocks cytokine/receptor synth (IL, TNF, GM-CSF) also ^gluconeogenesis/m catabolism --> high blood glucose to resist stress |
|
Glucocorticoids: toxicity?
|
^gastric acid/pepsin, mental changes, bone loss
|
|
List the Mineralcorticoids? (2) and their effects
|
Fludrocortisone: Na-retaining effect >> anti-inflamm effect
Desoxycorticosterone: less Na-retaining. NO anti-inflamm effect |
|
Mineralcorticoids: MOA?
|
help control body's water volume and [Na] & [K]
|
|
Combo OCP: E effect? P effect?
|
E: suppress ovulation
P: inhibit implantation |
|
P-only OCP: more effective or less effective than combo OCP?
|
less effective
|
|
What is the difference b/w Monophasic vs. Multiphasic combo OCPs?
|
Monophasic: same amt of E & P delivered in each pill
Multiphasic: diff amt of E & P in each pill (more closely approximates NL PHYSIOLOGIC CYCLE) |
|
List the Estrogens? (4)
|
1. Ethinyl estradiol
2. Premarin (conjugated E) 3. Mestranol 4. Diethylstilbestrol (DES) |
|
What are 2 E's used in combo OCPs?
|
[estrogens]
1. Ethinyl estradiol (more common) 2. Mestranol |
|
When would you need to increase dose of E's?
|
[estrogens]
when taking other Rx that ^P450 activity (eg. barbituates, carbamazepine, corticosteroids, griseofulvin, rifampin, etc.) |
|
List the classes of Progestins and differences?
|
Class I: mimic physiologic P (Medroxyprogesterone)
Class II: mimic T, usu used as the progestin part in combo OCP (SE: andorgenic!) (Norethindrone/Norgestrel) |
|
Impt factors before considering OCP therapy?
|
BMI, androgenic SE's, CI (smoking, E-responsive dysplasia)
|
|
CI to OCP thearpy?
|
h/o thromboembolic dz, vascular dz, MI, CV problems esp in smokers >35yo
h/o liver CA/dz (metabo) CA: br, repro tract abnl vaginal bleeding, preg |
|
HRT utility in menopause?
|
Useful against: osteoporosis, vasomotor Sx, CVD, vaginitis
eg. 17-B-estradiol |
|
Difference b/w ERT vs. HRT?
|
ERT: only E replacement
HRT: includes progestins |
|
List the SERMs?
|
[selective estrogen receptor modulators] "antiestrogens"
Clomiphene (also pro-fertility) Tamoxifen Raloxifene |
|
How do SERMs act as E agonist AND E antagonist?
|
[selective estrogen receptor modulator] "antiestrogens"
depends on tissue Tamoxifen: antagonist: Br (blocks ER+ tumors) agonist: bone (anti-osteoporosis), uterus (endometrial hyperplasia) |
|
Raloxifene: effects?
|
[selective estrogen receptor modulator] "antiestrogens"
same effects as Tamoxifen (blocks ER+ Br tumors, anti-osteoporosis, endometrial hyperplasia) but W/O endometrial effects so no risk of endometrial CA with Raloxifene |
|
What are 2 pharmacological approaches to Tx of infertility?
|
1. stimulate weak endocrine cycle (Clomiphene blocks negative feedback of E on hypoth and ant. pit --> GnRH --> FSH/LH)
2. start new cycle (HCG triggers ovulation) |
|
Ethinyl estradiol: advantages?
|
[estrogens]
synthetic E, less first-pass effect (more effective @ lower dose) |
|
Mestranol: MOA?
|
[estrogens]
synthetic E, metabo'd to ethinyl estradiol in body |
|
Diesthylstilbestrol: signif?
|
[estrogens] "DES"
non-steroidal w/ E activity, used to prevent miscarriage long ago --> ectopic preg, infertility, vaginal adenoCA |
|
Mifepristone: uses?
|
[antiprogesterones] "RU 486"
85% abortion rate, interferes with P, decline in B-hCG |
|
Type I vs. Type II DM? Basic Tx?
|
Type I: childhood, autoAbs against pancreatic B cells, no insulin; Tx: insulin
Type II: adult onset, insulin resistance, decreased insulin secretion; Tx: diet/lifestyle (early), insulin (late) |
|
List the Rapid-acting insulins?
|
[insulins]
Insulin aspart Insulin lispro Insulin glulisine can be injected right before meals |
|
List the Short-acting insulins?
|
[insulins]
Regular insulin bound to zinc for stability |
|
List the Intermediate-acting insulins?
|
[insulins]
Isophane insulin suspension (NPH) - complexed with protamine --> delays absorption of insulin by binding it usu mixed with faster-acting insulins |
|
List the Long-acting insulins?
|
[insulins]
Insulin detemir Insulin glargine provides steady-state, background insulin (last 12-24hrs) acid formulation = can't be mixed with other insuls |
|
List the Mixtures of insulins? Advantages?
|
[insulins]
NPL, Lispro NPA, Aspart combo of rapid- and intermediate-acting insulins provides tighter glycemic control |
|
Glucagon: uses?
|
from A cells of pancreas
Tx: severe hypOglycemia in DM type 1 (insulin secretogogue) --> ^blood glucose, ^insulin |
|
Are Oral antidiabetic drugs used in Type I or Type II DM?
|
Type II, no use in Type I (only insulin)
(eg. hypoglycemic drugs, antihyperglycemic drugs) |
|
Insulin: MOA?
|
binds to insulin-type receptors --> tyr kinase activity --> GLUT4 synth/recruitment --> glucose moves from blood to parenchyma via GLUT4
(GLUT2 in liver is insulin-independent, GLUT4 in skel m, adipose) |
|
List the Hypoglycemic drugs?
|
1. Sulfonylureas (Tolazamide, Glipizide, Glyburide)
2. Meglitinides (Nateglinide, Repaglinide) 3. Incretins (Exantide) |
|
List the Antihyperglycemic drugs?
|
1. Biguanides (Metformin)
2. Thiazolidinediones (Pioglitozone, Rosiglitazone) 3. a-glucosidase inhibitors (Acarbose) |
|
Sulfonylureas: MOA?
|
[oral hypoglycemics] (Tolazamide, Glyburide, Glipizide)
inhibit pancreatic K+ channel to stimulate insulin secretion |
|
Meglitinides: MOA?
|
[oral hypoglycemics] (Repaglinide, Nateglinide)
inhibit pancreatic K+ channel to stimulate insulin secretion can be used in pts with sulfur allergy |
|
Biguanides: MOA?
|
[antihyperglycemics] (Metformin)
^glycolysis ^gluc removal from blood \/gluconeogenesis \/gluc absorption from GI \/glucagon |
|
Biguanides: toxicity? CI?
|
[antihyperglycemics] (Metformin)
GI, lactic acidosis CI in alcoholics (renal/liver dz) |
|
Thiazolidinediones: MOA?
|
[antihyperglycemics] (Pioglitazine, Rosiglitazone)
@ adipose tissue: binds PPAR-y --> stims trxn of genes involved in lipid metabo and insulin signaling ^GLUT4 transporters |
|
Thiazolidinediones: toxicity? CI?
|
[antihyperglycemics] Pioglitazine, Rosiglitazone)
edema, metabo by P450 (^bioavailability of other P450 drugs, eg. OCPs) CI: HF pts |
|
Exantide: MOA?
|
[oral hypoglycemics] incretin analogue
glucagon-like peptide secreted in intestine in response to food ^blood glucose BUT also STIMS INSULIN SECRETION! (Tx: DM type II) |
|
a-glucosidase inhibitors: MOA?
|
[antihyperglycemic] (Acarbose)
competitively inhibits GI enzymes that breakdown sugars for uptake - blocks uptake of starch good for post-prandial but no effect on fasting glucose |
|
a-glucosidase inhibitors: toxicity?
|
[antihyperglycemic] (Acarbose)
flatulence, diarrhea |
|
List the Thyroid agents?
|
1. Thyroxine; T4 (less potent, more abundant than T3)
2. Levothyroxine: synthetic T4 3. Liothyronine: T3 (more potent, less abundant than T4) 4. Liotrix: synthetic T3/T4 mix |
|
List the Antithyroid agents? MOA?
|
Propylthiouracil, Methimazole
both inhibit thyroperoxidase (which adds I- to thyroglobulin) Propylthiouracil also inhibits deiodination of T4 peripherally (T4 no longer converted to T3) |
|
List the products of cyclooxygenase side of AA metabo?
|
1. AA metabo'd to PGG2 by COX
2. then to PGH2 3. then to PGE2, PGF2a, PGD2, PGI2, or TXA2 |
|
List the products of lipoxygenase side of AA metabo?
|
Leukotrienes
|
|
Misoprostol: MOA? uses?
|
[AA metabolites]
PGE1 analog suppresses gastric acid secretion (Pphlx: gastric ulcer in long-term aspirin therapy) |
|
Misoprostol: CI?
|
[AA metabolites] "PGE1 analog"
preg (it is an abortifacient!) |
|
Dinoprostone: MOA? uses?
|
[AA metabolites]
PGE2 analog via vaginal suppository dilate cervix for labor or as abortifacient |
|
Latanoprost: MOA? uses?
|
[AA metabolites]
PGF2a analog Tx: ophthalmic HTN (glaucoma) or as abortifacient |
|
Thromboxane: MOA?
|
[AA metabolites] (TXA2)
produced in plts: plt activator and vasoconstrictor (opposite of PGI2) involved in thromboembolic dz |
|
Prostacyclin: MOA?
|
[AA metabolites] (PGI2)
produced in endothelial cells: plt inhibitor and vasodilator (opposite of TXA2) |
|
LTB4: MOA?
|
[AA metabolites] lipoxygenase pathway
leukocyte chemotaxis (inflamm) |
|
LTC4/LTD4: MOA?
|
[AA metabolites] lipoxygenase pathway
bronchoconstriction |
|
List the NSAIDs?
|
Aspirin
Diflunisal Ibuprofen Naproxen Acetaminophen Diclofenac/Ketorolac Celecoxib (COX2i) Rofecoxib (COX2i) Zileuton (LOXi) |
|
Difference b/w COX-1 vs. COX-2?
|
COX-1: housekeeping enzyme in most tissue (non-inflamm)
COX-2: inducible, in inflamm cells selective COX-2 inhibitors (eg. Celecoxib, Rofecoxib) have less GI SE's (eg. ulcers) |
|
Aspirin: MOA?
|
[NSAIDs] (non-selective COXi)
hydrolyzed to acetic acid and salicylate IRREVERSIBLY binds plt COX (via acetylation) |
|
Aspirin: MOA?
|
[NSAIDs] (non-selective COXi)
antipyresis, antiinflamm, analgesia thromboembolic prophylaxis RA (high doses) may decrease risk of colon CA and Alzheimer's |
|
Aspirin: SE?
|
1. tinnitus, vertigo, GI (thwart mucosal barrier that relies on PGs)
2. Reye's syndrome: kids w/ viral infxn Tx'd w/ ASA = rapid liver failure and encephalitis 3. due to inhibition of COX-1: disrupt hemostasis, respiratory acidosis, coma |
|
Salicylates and its effect on inflamm vs. analgesia?
|
only ACETYLATED salicylates (like ASA) have both analgesia and antiinflamm effects
non-aceylated salicylates (Na salicylate) have antiinflamm effect but no analgesia effect bc the binding/inhib of COX is REVERSIBLE |
|
Acetaminophen: MOA? uses?
|
[NSAIDs] (COX3i)
p-aminophenol derivative, inhibits COX3 in brain no antiinflamm effect used for mild fever (antipyretic) and pain (analgesic) use instead of ASA in children (no risk for Reye's) |
|
Acetaminophen: toxicity?
|
[NSAIDs] (COX3i)
liver/kidney dz Antidote: N-acetylcysteine! (Tx: toxic liver metabolite) |
|
Ibuprofen: MOA? uses?
|
[NSAIDs] (non-selective COXi)
propionate derivative used widely: sports injuries, post-op pain, arthritis |
|
Ibuprofen: MOA? uses?
|
[NSAIDs] (non-selective COXi)
less SE vs. ASA chronic use: dyspepsia, HTN, gastric ulcer |
|
Naproxen: MOA? uses?
|
[NSAIDs] (non-selective COXi)
propionate derivative (same as ibuprofen, same uses) |
|
Naproxen: toxicity?
|
[NSAIDs] (non-selective COXi)
more irritating to GI than ibuprofen, MI |
|
Celecoxib: MOA? uses?
|
[NSAIDs] (selective COX-2i)
antiinflamm, analgesic minimal GI SE's and reduced effect on plt aggregation Tx; osteoarthritis, RA, menustrual cramps, post-dental surg, orthopedic surg |
|
Celecoxib: toxicity?
|
[NSAIDs] (selective COX-2i)
less GI SE's than non-selective COXi's contains sulfonamide moiety (allergic Rx) possible CV (stroke, MI) risk with COX2i (eg. Rofecoxib (Vioxx)) |
|
Rofecoxib: toxicity?
|
[NSAIDs] (selective COX-2i)
pulled from market (2004) for ^risk stroke, MI |
|
Zileuton: MOA?
|
Lipoxygenase inhibitor: no leukotriene synth
|
|
Diclofenac/Ketorlac: MOA?
|
[NSAIDs] (non-selective COXi)
acetic acid derivatives COX-1 affinity > COX-2 |
|
List the Antiarthritis agents?
|
1. NSAIDs
2. DMARDs (dz modifying antirheumatic drugs; eg. Methotrexate, Hydroxychloroquine, Sulfasalazine, Gold) |
|
What is a DMARD?
|
Disease Modifying AntiRheumatic Drugs
actually retarde the progression of dz (unlike NSAIDs that only deal with Sx) eg. Methotrexate, Hydroxychloroquine, Sulfasalazine, Gold |
|
Methotrexate: MOA? uses?
|
[DMARD] / [IBD]
folic acid analog with cytotoxic and immunosuppressive activity 1ST LINE Tx in RA due to rapid onset, few SE |
|
Methotrexate: toxicity?
|
[DMARD] [IBD]
hematotoxic teratogenic |
|
Hydroxychloroquine: uses?
|
[DMARD]
4-aminoquinolone retards RA but not bone erosion also used in Tx: malaria |
|
Hydroxychloroquine: toxicity?
|
[DMARD]
ocular toxicity |
|
Sulfasalazine: MOA? uses?
|
[DMARD] [IBD]
combo sulfonamide and salicylate separated by gut flora --> salicylate removes toxic oxygen metabolites produced by neutrophils retards RA |
|
Sulfasalazine: toxicity?
|
[DMARD] [IBD]
GI distress |
|
Azathioprine: MOA? uses?
|
[immunsuppressants, cytotoxic agents] [IBD]
inhibits purine synth inhibits cellular/humoral imm responses, inhibits clonal expansion given after organ transplant |
|
Cyclosporine: MOA? uses?
|
[immunsuppressants] [IBD]
inhibits IL-2 synth --> blocks T-cell recruitment (cellular imm) |
|
List the Antigout agents?
|
Colchicine (acute attack)
Probenecid (prohylaxis) Allopurinol (prohylaxis) |
|
Colchicine: MOA? uses?
|
[antigout]
binds tubulin in cells --> disrupts polymerization = cell motility = decrease leukocyte migration into joints for acute attack/inflamm of gout |
|
Probenecid: MOA? uses?
|
[antigout] uricosuric
^organic acid secretion (eg. uric acid) by competing for uptake receptors in proximal tubules for prophylaxis of gout |
|
Allopurinol: MOA? uses?
|
[antigout]
inhibits xanthine oxidase --> decrease uric acid synth drug of choice for long-term therapy of gout |
|
Describe the synth of histamine and its cellular sources?
|
synth from histidine by histidine decarboxylase
stored in mast cells, basophils, neurons, epidermis, gastric mucosa |
|
What are the releasers of histamine?
|
1. IgE Abs on mast cells (type I hypersensitivity)
2. peptides that contain basic aa (Arg, Lys) 3. complement derivatives (anaphylatoxins: C3a, C4a, C5a) 4. substance P 5. bee/wasp venom (melittin, polistes kinin) |
|
What are the inhibitors of histamine rls?
|
anything that ^cAMP
B-receptor activation and cAMP accumulation (eg. isoproterenol, Epi, theophylline) |
|
Effects of activation of H1 receptors?
|
(Gq) SM effects: bronchoconstriction, vasodilation, edema (IgE-med allergy, mast cells)
|
|
Effects of activation of H2 receptors?
|
(Gs) parietal cell --> gastric acid secretion, (-) feedback on histamine via ^cAMP
|
|
Effects of activation of H3 receptors?
|
(Gi) presynaptic inhibitory heteroreceptor (inhibits rls of other NTs: DA, GABA, ACh, NE, and 5-HT)
Gi = decrease cAMP |
|
How is histamine degraded?
|
via monoamine oxidase (MAO) and diamine oxidase
|
|
What are the specific actions of histamine?
|
1. IgE-med Type I hypersensitivity (rhinitis, urticaria, edema)
2. acid secretion in stomach 3. NT |
|
List the H1 receptor antagonists?
|
Chlorpheneramine
Diphenhydramine (Benedryl) (also anti-emetic) Fexofenadine Loratadine/Terfenadine |
|
Indications of H1 receptor antags?
|
IgE/immediate Type 1 hypersensitivities: allergy, pollinosis, urticaria, hay fever,
not indicated for asthma, cold |
|
H1 receptor antags: toxicity?
|
(Chlorpheneramine, Diphenhydramine, Fexofenadine)
drowsiness (esp w/ EtOH), anticholinergic (dry mouth, blurred vision) |
|
Loratadine/Terfenadine: toxicity?
|
[H1 receptor antags]
serious SE in hepatic dysfxn (bc metabo'd by P450) w/ concomitant admin of erythromycin or in OD --> ventricular arrhythmias, QT prolongation |
|
List the H2 receptor antags?
|
Cimetidine
Rantidine Famotidine Nizatidine |
|
Cimetidine: uses?
|
[H2 receptor antag] "Tagamet"
inhibits secretion caused by histamine/gastrin/ACh Tx: ulcers, Zollinger-Ellison syndrome |
|
Cimetidine: toxicity?
|
[H2 receptor antags]
anti-androgen effects (gynecomastia, impotence, PRL secretion) interferes with metabo of other P450 drugs (warfarin, lidocaine, phenobarbitol) |
|
Rantidine vs. Cimetidine: uses?
|
[H2 receptor antags] "Zantac"
Rantidine: binds P450 less (less SE) longer-lasting (more effective in lower doses) furan subunit (instead of imidazole ring) |
|
Famotidine: describe?
|
[H2 receptor antags]
thiazole subunit (instead of imidazole ring of Cimetidine) more effective than Ranitidine no P450 interactions (45% absorbed, urinated unchanged) (Nizatidine has no P450 interactions too but 90% abs) recall: Rantidine: binds P450 less (less SE) vs. Cimetidine longer-lasting (more effective in lower doses) vs. Cimetidine furan subunit (instead of imidazole ring of Cimetidine) |
|
Nizatidine: describe?
|
[H2 receptor antag]
no P450 interactions (90% absorbed, urinated unchanged) |
|
List the Pro-emetic drugs?
|
Ipecac (Emetine)
Apomorphine |
|
Ipecac: MOA? uses?
|
[pro-emetics]
direct effects on chemoreceptor trigger zone (medulla), which talks to vomiting center for oral poisoning |
|
Apomorphine vs. Ipecac?
|
[pro-emetics]
Apormorphine more potent and rapid-acting |
|
List the Anti-emetic drugs?
|
1. Antihistamines (Diphenhydramine, Meclizine)
2. Anticholinergics (Scopolamine) 3. D2 antags (Metoclopramide, Promethazine) 4. 5HT3 antags (Ondansetron) 5. Cannabinoids (Marijuana, Dronabinol) |
|
Which anti-emetics are used for motion sickness and post-op nausea?
|
1. Antihistamines (Diphenhydramine, Meclizine)
2. Anticholinergics (Scopolamine; dermal patch) |
|
Which anti-emetics are used for chemo/radio-induced nausea?
|
1. D2 antags (Metoclopramide, Promethazine)
2. 5-HT3 antags (Ondansetron) 3. Cannabinoids (Marijuana, Dronabinol) |
|
List the Pro-kinetic (GI motility) drugs? uses?
|
1. Cholinergics (Bethanachol, Neostigmine)
2. 5-HT4 agonists (Metoclopramide, Tegaserod) 3. others (Domperidone, Erythromycin) post-op paralysis, diabetic gastroparesis, GERD (by ^LES P) |
|
Why aren't the Cholinergic pro-kinetic drugs used anymore?
|
(Bethanachol, Neostigmine)
non-specificity |
|
Metoclopramide: toxicity?
|
[5HT4 agonist pro-kinetic]
Parkinsonism, ^PRL |
|
Domperidone: MOA? uses?
|
[antidopaminergic anti-emetic, pro-kinetic]
unlike Metoclopramide (5-HT4 agonist), can be used in Parkinson's bc does NOT cross BBB |
|
Erythromycin: uses in GI?
|
[pro-kinetic]
direct effect on gastric SM for diabetic gastroparesis |
|
List the Antidiarrheal agents?
|
1. Intraluminal (Kaopectate, Metamucil, Bismuth salycilate (peptobismol))
2. Opiods (Loperamide, Diphenoxylate, Difenoxin) 3. Others (Octreotide, Cholestryamine) |
|
Intraluminal antidiarrheal agents: MOA?
|
^stool viscosity and absorb water
Kaopectate (clay) Metamucil (fiber) Bismuth salycilate (peptobismol) |
|
Opiod antidiarrheal agents: MOA?
|
inhibit enteric nerves presynpatically
Loperamide (imodium) Diphenoxylate/Difenoxin (CNS effects, Rx only) |
|
Octreotide: uses?
|
[antidiarrheal]
antisecretory effects, decreases colonic tone for severe AIDS/chemo-induced diarrhea |
|
Cholestyramine: MOA? uses?
|
[antidiarrheal] [bile acid sequestrant/antihyperlipidemic]
binds bile salts so no longer osmotically active for ileal resection |
|
List the Laxatives?
|
1. Bulk (Dietary fiber, Methylcellulose, Psyllium husk)
2. Osmotic (Mg salts, Phosphates, Glycerin, Lactulose, Polyethylene glycol soln) 3. Stimulant (Bisacodyl, Castor oil, Senna, Cascara) 4. Stool softeners (Mineral oil, Docusate) |
|
Bulk laxatives: MOA?
|
(Dietary fiber, Methylcellulose, Psyllium husk)
retain water in stools and support bacterial growth --> ^bacterial fermentation produces short-chain fatty acids that stim colonic motility |
|
Osmotic laxatives: MOA? CI?
|
(Mg salts, Phosphates, Glycerin, Lactulose, Polyethylene glycol soln)
pulls water into colon CI: renal/cardiac dz (can produce electrolyte/fluid imbalances) |
|
Stimulant laxatives: MOA?
|
(Bisacodyl, Castor oil, Senna, Cascara)
directly stim colonic motility, enhance secretion of fluid/electrolytes |
|
Stool softener: MOA?
|
(Mineral oil, Docusate)
^water/fat into stool |
|
List the Antacids?
|
Bicarbonate (alkaseltzer)
Ca carbonate (tums) Mg hydroxide (laxative effect) Al hydroxide (constipating effect) |
|
Antacids: MOA?
|
[Bicarbonate (alkaseltzer)
Ca carbonate (tums) Mg hydroxide (laxative effect) Al hydroxide (constipating effect)] weak organic bases that neutralize stomach acid |
|
H2 histamine antags that block parietal cell stimulation and lower stomach acid? uses?
|
(-idine)
Cimetidine Ranitidine Famotidine Nizatidine GERD, PUD, non-ulcer dysplasia (1st line = PPIs) |
|
List the PPI's?
|
(-prazole)
Omeprazole Lansoprazole Rabeprazole Pantoprazole |
|
PPI: MOA?
|
(-prazole)
Omeprazole Lansoprazole Rabeprazole Pantoprazole bind covalently and IRREVERSIBLY to proton pumps and deactivate them (NEW pump must be synth'd to restore activity) 1ST LINE against GERD, PUD (more effective than H2 antags) |
|
What is the 1st line Tx for GERD and PUD?
|
PPI (-prazole):
Omeprazole Lansoprazole Rabeprazole Pantoprazole (more effective than H2 antags) (-idine) Cimetidine Ranitidine Famotidine Nizatidine |
|
List the Protective agents against peptic ulcers?
|
Misoprostol (PGE analog)
Sucralafate (sulfated polysacch) |
|
Misoprostol: MOA? uses? SE?
|
[protective agents]
PGE analog, inhibits acid secretion and promotes mucus and HCO3- secretion for peptic ulcers/recurrence not used a lot due to GI upset, diarrhea |
|
Sucralafate: MOA? uses?
|
[protective agent]
sulfated polysacch --> polymerizes in acidic environ (stomach acid) --> forms protective layer and buffers acid for peptic ulcers/recurrence |
|
List the IBD agents?
|
1. Aminosalicylates (Sulfasalazine, Mesalamine)
2. Glucocorticoids (Prednisone, Hydrocortisone, Budesonide) 3. Cytostatic/Immunosuppressants (Cyclosporine, 6-mercaptopurine, Azathioprine, Methotrexate) 4. Anti-TNF (Infliximab) |
|
Aminosalicylates: MOA?
|
[IBD agents] (Sulfasalazine [DMARD], Mesalamine)
non-absorbable NSAIDs: not active until cleaved by gut flora, releases salicylic acid (NSAID) --> inhibits synth of PGs/leukotrienes (inflamm mediators) |
|
Aminosalicylates: toxicity?
|
[IBD agents] (Sulfasalazine [DMARD], Mesalamine)
arthralgias, BM suppression, severe hypersensitivity rxns |
|
List the Glucocorticoids used in IBD?
|
Glucocorticoids:
Prednisone (intemediate-acting) Hydrocortisone (short-acting) Budesonide |
|
List the cytostatic/immunosuppressant agents used in IBD? MOA?
|
1. Cyclosporine (inhibits IL-2 synth & T cell recruitment)
2. 6-mercaptopurine (interferes w/ nucleotide/RNA/DNA synth) 3. Azathioprine (interferes w/ purine/DNA synth) 4. Methotrexate (FA analog) |
|
Infliximab: MOA?
|
[IBD agents, immunosuppressant]
anti-TNFa mAb |
|
List the Antihyperlipidemic drugs?
|
1. Statins (Atorvastatin, Simvastatin, Lovastatin, Pravastatin)
2. Fibric Acid derivatives (Gemfibrozil, Fenofibrate, Clofibrate) 3. Bile Acid sequestrants (Cholestyramine, Colestipol) 4. others (Niacin, Ezetimibe) |
|
Antihyperlipidemic drugs: effects on lipids?
|
Statins: lower LDL, ^HDL
Fibric Acid derivatives: lower VLDL, TG, ^HDL Niacin: lower LDL, VLDL, TG, ^HDL Bile Acid sequestrants: lower LDL, chol Ezetimibe: lower LDL, chol |
|
Statins: MOA?
|
[antihyperlipidemic/antiatherosclerotic agents] (Atorvastatin, Simvastatin, Lovastatin, Pravastatin)
competitively inhibit HMG-CoA reductase (key enzyme for de novo chol synth) --> lower LDL --> ^HDL (HDL/LDL) |
|
Statins: pros/cons?
|
[antihyperlipidemic/antiatherosclerotic agents] (Atorvastatin, Simvastatin, Lovastatin, Pravastatin)
pros: specific, effective, well-tolerated cons: long term safety unknown, $$$, CI: preg/nursing (teratogenic) |
|
Fibric Acids: MOA?
|
[antihyperlipidemic/antiatherosclerotic agents] (Gemfibrozil, Fenofibrate, Clofibrate)
bind with PPARs (peroxisome proliferator activated receptors) --> stim lipoprotein lipase (from adipose tissue) --> ^clearance of lipids, ^synth HDL --> lower VLDL, TG --> ^HDL (HDL/LDL) |
|
Fibric Acids: pros/cons?
|
[antihyperlipidemic/antiatherosclerotic agents] (Gemfibrozil, Fenofibrate, Clofibrate)
pros: safe, effective, well-tolerated, cheaper than statins, potential antithrombotic effects cons: more effective at reducing TG than chol (no effect on LDL), Clofibrate not used due to toxicity SE: chol gallstones! |
|
Niacin (Nicotinic Acid): MOA?
|
[antihyperlipidemic/antiatherosclerotic agents]
inhibit hormone-sensitive lipases --> decrease FFA available to liver for synth of TG --> lower LDL, TG, VLDL --> ^HDL (HDL/LDL) |
|
Niacin (Nicotinic Acid): pros/cons?
|
[antihyperlipidemic/antiatherosclerotic agents]
pros: long clinical experience, least expensive cons: flushing, itchiness, GI discomfort, reactivate gout via liver rxns! CI: diabetics, preg |
|
Bile Acid sequestrants: MOA?
|
[antihyperlipidemic/antiatherosclerotic agents] (Cholestyramine, Colestipol)
oral (GI action, no bloodstream) anion exchange resins bind neg-charged bile acids in SI --> excreted (will increase chol synth/TO) --> lower LDL, chol use in combo with Statins to reduce increased chol synth/TO |
|
Bile Acid sequestrants: pros/cons?
|
[antihyperlipidemic/antiatherosclerotic agents] (Cholestyramine, Colestipol)
pros: safe, effective cons: GI effects (interferes with GI drug abs), exacerbates hypertriglyceridemia CI: warfarin |
|
Ezetimibe: MOA?
|
[antihyperlipidemic/antiatherosclerotic agents]
prodrug --> active glucuronide form inhibits dietary chol uptake by jej epith by binding to protein Niemann-Pick-C1-Like1 (NPC1L1) --> excreted (will increase chol synth/TO) --> lower LDL, chol use in combo with Statins to reduce increased chol synth/TO |
|
Ezetimibe: pros/cons?
|
[antihyperlipidemic/antiatherosclerotic agents]
pros: safe, effective, can use as monotherapy in Statin-intolerant pts cons: no effect on TG absorption, can also cause hepatotoxicty in combo w/ Statins |
|
Etanercept: MOA? uses?
|
[immunosuppressant]
TNF inhibitor by acting like a TNF receptor for autoimmune dz |
|
Adalimumab: MOA? uses?
|
[immunosuppressant]
anti-TNFa mAb for autoimmune dz |
|
Anakinra: MOA? uses?
|
[immunosuppressant]
IL-1 receptor antag for RA |
|
Which carcinogens require P450-mediated oxidation to be able to interact with DNA?
|
Benzo(a)pyrene (polycyclic aromatic hydrocarbon)
Aflatoxin B1 (Mycotoxin) |